NCT00563784
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Bronchial Neoplasms, +17 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Adenocarcinoma, Clear Cell
Explore clinical trials studying Adenocarcinoma, Clear Cell. Study availability and eligibility vary by location and protocol.
19 public trials
5 recruiting studies
Adenocarcinoma, Clear Cell trial results
Completed
Ovarian Clear Cell Adenocarcinoma Review
NCT02129036
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +19 more
- Locations
-
Not specified
NCT01824615
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +19 more
- Locations
-
- Cathay General Hospital Taipei, Taiwan
NCT00455975
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +15 more
- Locations
-
- Florida Cancer Specialists Fort Myers, Florida, United States
- Northeast Georgia Medical Center Gainesville, Georgia, United States
- Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States
- Center for Cancer and Blood Disorders Bethesda, Maryland, United States
Active, Not Recruiting
Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
NCT01582204
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +14 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
NCT03355976
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +28 more
- Locations
-
- University of Illinois Chicago Chicago, Illinois, United States
- Rhode Island Hospital Providence, Rhode Island, United States
- Women & Infants Hospital Providence, Rhode Island, United States
- The Miriam Hospital Providence, Rhode Island, United States
Active, Not Recruiting
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
NCT05544929
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
- Locations
-
- Massachusetts General Hospital . Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- NYU School of Medicine New York, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, Not Recruiting
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
NCT05032040
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +34 more
- Locations
-
- Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
- UCSD Moores Cancer Center La Jolla, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- UCLA Medical Center Los Angeles, California, United States